Earlier diagnosis, individual prognosis and access to more effective disease management
Improved decision support tools
for HEALTHCARE SYSTEMS
Support in delivering improved care and better outcomes for patients
for PHARMACEUTICAL COMPANIES
Improved efficiency in developing new medications for ILDs
for MEDICAL TECHNOLOGY VENDORS
Ability to incorporate biomarker analysis tools into products — a potential differentiator
for ACADEMIC INSTITUTIONS
Enhance current research projects and magnify contributions designed to contribute to the fight against IPF and other ILDs
First steps to becoming a member
Additional member partners, collaborators and contributors are welcome and encouraged.
Get the latest OSIC news delivered right to your inbox
No spam. Just news.
Indicates required field
Please pick one
I am a clinician, researcher, or patient advocate
I am a innovator, creator, or entrepreneur
I am a patient
I am a member of the press
I do not fall into the above categories
By clicking the "subscribe to OSIC news" button below, you agree you want to receive news and other promotional materials from and about OSIC by email, and you consent to OSIC processing your personal data for this purpose.
Subscribe to OSIC News
Copyright © 2021
Open Source Imaging Consortium (OSIC). All rights reserved.
OSICild on Twitter